Idra stock price target

Analysts Offer Insights on Healthcare Companies: ACADIA ... May 03, 2019 · Idera (IDRA) H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Idera today and set a price target of $14. The company’s shares closed yesterday at $3.06, close to its 52-week low of $2.25. Ramakanth commented: “We maintain our Buy rating of IDRA and our 12-month price target of $14.00 per share. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Upgrades ...

Nov 04, 2019 · 3 Wall Street analysts have issued ratings and price targets for Idera Pharmaceuticals in the last 12 months. Their average twelve-month price target is $8.00, suggesting that the stock has a possible upside of 463.38%. The high price target for IDRA is … Idera Pharmaceuticals, Inc. Common Stock (IDRA) Stock ... Idera Pharmaceuticals, Inc. Common Stock (IDRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. IDRA | Idera Pharmaceuticals Inc. Analyst Estimates ... Oct 09, 2019 · Idera Pharmaceuticals Inc. analyst estimates by MarketWatch. View IDRA revenue estimates and earnings estimates, as well as analyst recommendations.

11 Feb 2020 Idera Pharmaceuticals Inc. (NASDAQ: IDRA) is -12.64% lower on its value in 0 analysts have rated the stock as a Sell or Underperform.

IDRA Idera Pharmaceuticals, Inc. Stock Quote Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology in the United States. It offers Tilsotolimod, a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors Idera Pharmaceuticals Inc (NASDAQ:IDRA) Expected to Post ... One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Idera Pharmaceuticals currently has an average rating of … Idera Pharmaceuticals (NASDAQ:IDRA) Stock Quotes and News ... Jan 01, 2010 · Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.

Idera (IDRA) closes enrollment in the late-stage ILLUMINATE-301 study, evaluating the combo of tilsotolimod plus Yervoy in patients with anti-PD-1 refractory advanced melanoma. Simply Wall St. Does Idera Pharmaceuticals, Inc.'s (NASDAQ:IDRA) CEO Salary Compare Well With Others? Vinnie, Vin Milano

Idera Pharmaceuticals, Inc. Common Stock (IDRA) Real-Time ... Mar 27, 2020 · IDRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low IDRA Stock Quote - Idera Pharmaceuticals, Inc. Common ... Stock quote for Idera Pharmaceuticals, Inc. Common Stock Common Stock (IDRA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. IDRA Stock Price & Charts | Idera Pharmaceuticals In depth view into IDRA (Idera Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Idera Pharmaceuticals, Inc. (IDRA) Stock Price, Quote ...

IDRA | Idera Pharmaceuticals Inc. Analyst Estimates ...

IDRA | Idera Pharmaceuticals Inc. Analyst Estimates ...

Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research 

PRICE TARGET No. of Brokers 5 Median Target 8.200 USD Highest Target 10.000 USD Lowest Target 5.000 USD Analyst Opinions for Idera Pharmaceuticals Inc Registered Shs Stock quotes by finanzen Idera Pharmaceuticals, Inc. (IDRA) Stock Price, Quote ... Find the latest Idera Pharmaceuticals, Inc. (IDRA) stock quote, history, news and other vital information to help you with your stock trading and investing. HC Wainwright Reiterates Buy Rating for Idera ...

Jan 01, 2010 · Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Idera Pharmaceuticals (IDRA) Stock Price History | wallmine